Annals of Neurology

Journal

Publication Venue For

  • Correction to: “Optimizing Patient Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT): A Prospective Multicenter Cohort Study of Imaging Selection” (Annals of Neurology, (2020), 87, 3, (419-433), 10.1002/ana.25669).  88:1056-1057. 2020
  • Real-World Effectiveness of Initial Disease-Modifying Therapies in Pediatric Multiple Sclerosis.  88:42-55. 2020
  • Optimizing Patient Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT): A Prospective, Multicenter Cohort Study of Imaging Selection.  87:419-433. 2020
  • Using global team science to identify genetic parkinson's disease worldwide.  86:153-157. 2019
  • Gender Inequities in the Multiple Sclerosis Community: A Call for Action.  84:958-959. 2018
  • N-acetylcysteine targets 5 lipoxygenase-derived, toxic lipids and can synergize with prostaglandin E2 to inhibit ferroptosis and improve outcomes following hemorrhagic stroke in mice.  84:854-872. 2018
  • NBEA: Developmental disease gene with early generalized epilepsy phenotypes.  84:788-795. 2018
  • 18F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study.  82:622-634. 2017
  • Dendritic spines provide cognitive resilience against Alzheimer's disease.  82:602-614. 2017
  • Incidence and impact of subclinical epileptiform activity in Alzheimer's disease.  80:858-870. 2016
  • Glucocerebrosidase, Parkinson disease, and the “senses and intellect”.  80:660-661. 2016
  • Long-term evolution of multiple sclerosis disability in the treatment era.  80:499-510. 2016
  • Alzheimer's disease pathology is attenuated in a CD38-deficient mouse model.  78:88-103. 2015
  • Apraxia in anti-glutamic acid decarboxylase-associated stiff person syndrome: Link to corticobasal degeneration?.  77:173-175. 2015
  • Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial.  78:248-257. 2015
  • Training for a neurology career in a rare disease: The role of cyberconsults.  77:738-740. 2015
  • A fatal case of JC virus meningitis presenting with hydrocephalus in a human immunodeficiency virus-seronegative patient..  76:140-147. 2014
  • Hyperintense cortical signal on magnetic resonance imaging reflects focal leukocortical encephalitis and seizure risk in progressive multifocal leukoencephalopathy..  75:659-669. 2014
  • The α2B-adrenergic receptor is mutant in cortical myoclonus and epilepsy.  75:77-87. 2014
  • UBQLN2 mutation causing heterogeneous X-linked dominant neurodegeneration.  75:793-798. 2014
  • Randomized study combining interferon and glatiramer acetate in multiple sclerosis.  73:327-340. 2013
  • Reply to Dr Ismailov.  73:146-147. 2013
  • Short- and long-term sunlight radiation and stroke incidence.  73:32-37. 2013
  • Mouse models of frontotemporal dementia.  72:837-849. 2012
  • Laminin alpha 2 enables glioblastoma stem cell growth.  72:766-778. 2012
  • Meta-analysis of Parkinson's Disease: Identification of a novel locus, RIT2.  71:370-384. 2012
  • Reply.  70:666-667. 2011
  • Incident cognitive impairment is elevated in the stroke belt: The REGARDS Study.  70:229-236. 2011
  • Got milk?.  70:3-4. 2011
  • Disparities in stroke incidence contributing to disparities in stroke mortality.  69:619-627. 2011
  • Exome sequencing allows for rapid gene identification in a Charcot-Marie-Tooth family.  69:464-470. 2011
  • Lipids and stroke: Looking for risk in all the wrong places?.  69:597-599. 2011
  • Comparative analysis of therapeutic options used for myasthenia gravis.  68:797-805. 2010
  • Rett syndrome diagnostic criteria: Lessons from the Natural History Study.  68:951-955. 2010
  • Rett syndrome: Revised diagnostic criteria and nomenclature.  68:944-950. 2010
  • Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis.  67:749-760. 2010
  • Beyond diagnosis: What biomarkers are teaching us about the "bio"logy of Alzheimer disease.  67:283-285. 2010
  • Considerations on discontinuing natalizumab for the treatment of multiple sclerosis.  68:409-411. 2010
  • Outcome of Optic Neuritis in Pediatric Demyelinating Disease.  68:S86-S86. 2010
  • Effect of epilepsy magnetic source imaging on intracranial electrode placement.  65:716-723. 2009
  • Early imaging correlates of subsequent motor recovery after stroke.  65:596-602. 2009
  • Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: A meta-analytic approach.  65:268-275. 2009
  • Reperfusion normalizes motor activation patterns in Large-Vessel disease.  65:203-208. 2009
  • Estimated 10-year stroke risk by region and race in the United States: Geographic and racial differences in stroke risk.  64:507-513. 2008
  • Functional imaging: I. Relative predictive value of intracranial electroencephalography.  64:25-34. 2008
  • Functional imaging: II. Prediction of epilepsy surgery outcome.  64:35-41. 2008
  • Care seeking after stroke symptoms.  63:466-472. 2008
  • Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease.  62:137-144. 2007
  • DBH -1021C→T does not modify risk or age at onset in Parkinson's disease.  62:99-101. 2007
  • National Institutes of Health: The lottery.  62:106. 2007
  • Interferon-β for multiple sclerosis: Long-term benefits?.  61:283-285. 2007
  • A second major histocompatibility complex susceptibility locus for multiple sclerosis.  61:228-236. 2007
  • Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double-blind, placebo-controlled trial.  61:14-24. 2007
  • Heterozygous parkin point mutations are as common in control subjects as in Parkinson's patients.  61:47-54. 2007
  • Simvastatin enhances learning and memory independent of amyloid load in mice.  60:729-739. 2006
  • Localization of LRRK2 to membranous and vesicular structures in mammalian brain.  60:557-569. 2006
  • Platform Session 4 (36-43).  60:S139-S141. 2006
  • A longitudinal functional magnetic resonance imaging study of language development in children 5 to 11 years old.  59:796-807. 2006
  • Magnetic source imaging versus intracranial electroencephalogram in epilepsy surgery: A prospective study.  59:835-842. 2006
  • A locus for generalized tonic-clonic seizure susceptibility maps to chromosome 10q25-q26.  58:449-458. 2005
  • False-positive SCA8 gene test in a patient with pathologically proven multiple system atrophy [1].  57:462-463. 2005
  • Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander disease.  57:310-326. 2005
  • Unusual variants of Alexander's disease.  57:327-338. 2005
  • Hypoperfusion without stroke alters motor activation in the opposite hemisphere.  56:796-802. 2004
  • Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.  54:93-101. 2003
  • Altered hippocampal muscarinic receptors in acetylcholinesterase-deficient mice.  53:788-796. 2003
  • Parkin mutations and susceptibility alleles in late-onset Parkinson's disease.  53:624-629. 2003
  • Quantitative neuropathological changes in presymptomatic Huntington's disease.  49:29-34. 2001
  • Decreased cerebrospinal fluid levels of β-phenylethylamine in patients with Rett syndrome.  47:801-803. 2000
  • Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes.  47:670-679. 2000
  • Distribution of the mRNAs encoding torsinA and torsinB in the normal adult human brain.  46:761-769. 1999
  • Distribution of the mRNAs encoding torsinA and torsinB in the normal adult human brain.  46:761-769. 1999
  • The hereditary dystonias: An emerging story with a twist.  44:4-5. 1998
  • Dystonia with motor delay in compound heterozygotes for GTP- cyclohydrolase I gene mutations.  44:10-16. 1998
  • Expression of the early onset torsion dystonia gene (DYT1) in human brain.  43:669-673. 1998
  • Apolipoprotein E genotypes and age at onset of Parkinson's disease [4] (multiple letters).  44:294-295. 1998
  • On the pathological progression of Huntington's disease [1] (multiple letters).  44:148. 1998
  • Decreased cerebrospinal fluid levels of substance P in patients with Rett syndrome.  42:978-981. 1997
  • Modulation of the age at onset of Parkinson's disease by apolipoprotein E genotypes.  42:655-658. 1997
  • Accumulation of β-amyloid precursor protein in HIV encephalitis: Relationship with neuropsychological abnormalities.  42:34-40. 1997
  • Intrinsic epileptogenesis of hypothalamic hamartomas in gelastic epilepsy.  42:60-67. 1997
  • CAG repeat number governs the development rate of pathology in huntington's disease.  41:689-692. 1997
  • Recommendations from the national multiple sclerosis society clinical outcomes assessment task force.  42:379-382. 1997
  • Opportunities and challenges in academic neurology: Report of the long range planning committee of the American Neurological Association.  39:693-699. 1996
  • Developmental dyslexia: A motor-articulatory feedback hypothesis.  39:407-412. 1996
  • Clinical outcomes assessment in multiple sclerosis.  40:469-479. 1996
  • Clinical outcomes and documentation of partial beneficial effects of immunotherapy for multiple sclerosis.  37:5-6. 1995
  • Huntington's disease gene: Regional and cellular expression in brain of normal and affected individuals.  37:218-230. 1995
  • Increased Risk of Parkinson's Disease in Relatives of Patients.  37:685-685. 1995
  • Reply.  37:685-685. 1995
  • Increased risk of Parkinson's disease in parents and siblings of patients.  36:659-661. 1994
  • Neuronal migration disorders: Positron emission tomography correlations.  35:290-297. 1994
  • Predictive value of induction of psychogenic seizures by suggestion.  35:359-361. 1994
  • Rett syndrome: Controlled study of an oral opiate antagonist, naltrexone.  35:464-470. 1994
  • Visual grasp in corticobasal degeneration.  36:679-679. 1994
  • VISUAL PHENOMENA LIMITED TO THE HEMIANOPIC FIELD IN LESIONS OF THE CENTRAL VISUAL PATHWAYS.  34:279-279. 1993
  • Correlation of myelin basic protein‐like material in cerebrospinal fluid of multiple sclerosis patients with their response to glucocorticoid treatment.  33:10-17. 1993
  • Retinal ganglion cells in Alzheimer's disease and aging.  33:248-257. 1993
  • Mitochondrial oxidative phosphorylation defects in Parkinson's disease.  32:113-114. 1992
  • Preferential loss of striato‐external pallidal projection neurons in presymptomatic Huntington's disease.  31:425-430. 1992
  • Reply.  32:227-227. 1992
  • Cerebral amyloid angiopathy without and with cerebral hemorrhages: A comparative histological study.  30:637-649. 1991
  • Excitatory amino acid binding sites in the caudate nucleus and frontal cortex of huntington's disease.  30:785-793. 1991
  • Mitochondrial oxidative phosphorylation defects in parkinson's disease.  30:332-339. 1991
  • Sleep-related focal motor seizures in bilateral central macrogyria..  28:840-842. 1990
  • Estimation of familial risk in Alzheimer's disease.  27:338-340. 1990
  • Phosphorus magnetic resonance spectroscopy of patients with mitochondrial cytopathies demonstrates decreased levels of brain phosphocreatine.  27:626-630. 1990
  • Reply.  27:340-341. 1990
  • Reply.  28:840-840. 1990
  • Positron emission tomography in manganese intoxication..  26:647-651. 1989
  • Assessment of genetic risk for alzheimer's disease among first‐degree relatives.  25:485-493. 1989
  • Cerebrospinal fluid biogenic amines and biopterin in rett syndrome.  25:56-60. 1989
  • Ideational apraxia: A deficit in tool selection and use.  25:190-193. 1989
  • An isoelectric focusing study in herpes simplex virus encephalitis.  24:227-232. 1988
  • Reply.  22:96-97. 1987
  • Rett's syndrome: Characterization of respiratory patterns and sleep.  21:377-382. 1987
  • Bilateral lucency of the globus pallidus complicating methylmalonic acidemia.  20:364-366. 1986
  • Facioscapulohumeral dystrophy presenting in infancy with facial diplegia and sensorineural deafness.  17:513-516. 1985
  • The role of plasma lipids in carotid bifurcation atherosclerosis.  17:301-303. 1985
  • Acquired immune deficiency syndrome and multiple tract degeneration in a homosexual man.  15:502-505. 1984
  • Mechanisms of acute carotid stroke.  6:245-252. 1979
  • Mechanisms underlying hemispatial neglect.  5:166-170. 1979
  • Nonsensory neglect.  3:505-508. 1978
  • International Standard Serial Number (issn)

  • 0364-5134
  • Electronic International Standard Serial Number (eissn)

  • 1531-8249